Description
CANCELLED OBLIGATION #657A03003 THE JANUARY 2020 FILL DID NOT OCCUR.
Base award description: DELIVERY OF BALVERSA (ERDAFITINIB) 4MG TABS 56/BOTTLE TO BE SENT MONTHLY FOR FIVE MONTHS
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-12-17+$75,453= $75,453
- Mod P000012020-01-29-$60,362= $15,091
- Mod P000022020-01-29+$60,362= $75,453
- Mod P000032020-07-10-$15,091= $60,362
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-12-17 | +$75,453 | $75,453 | DELIVERY OF BALVERSA (ERDAFITINIB) 4MG TABS 56/BOTTLE TO BE SENT MONTHLY FOR FIVE MONTHS |
| Mod P00001· FUNDING ONLY ACTION | 2020-01-29 | −$60,362 | $15,091 | DELIVERY OF BALVERSA (ERDAFITINIB) 4MG TABS 56/BOTTLE TO BE SENT MONTHLY FOR FIVE MONTHS |
| Mod P00002· FUNDING ONLY ACTION | 2020-01-29 | +$60,362 | $75,453 | CREATED INDIVIDUAL OBLIGATION #'S FOR LINE ITEMS 0002-0005 |
| Mod P00003· FUNDING ONLY ACTION | 2020-07-10 | −$15,091 | $60,362 | CANCELLED OBLIGATION #657A03003 THE JANUARY 2020 FILL DID NOT OCCUR. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HHDAGRZPBBZ4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25222P0083 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,400 | FY2022 |
| 36C25222P0058 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $6,862 | FY2022 |
| 36C25222P0059 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,400 | FY2022 |
| 36C25222P0050 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $11,947 | FY2022 |
| 36C25222P0045 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,366 | FY2022 |
| 36C25222P0044 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,533 | FY2022 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25520P0141_3600_-NONE-_-NONE- · retrieved 2026-09-26.